Former biologics boss Peter Marks had a vision. With the FDA’s latest draft guidance, it’s coming to fruition. Speaking with BioSpace, current CBER leader Karim Mikhail said the “adapted pathway” is ...
With companies including AstraZeneca, Pfizer and Revolution Medicines clamoring to get in on Summit Therapeutics’ ...
New fixed, single-room configuration is designed to make DeepOCT+NIRS Imaging and X1-FFR physiology readily available for ...
Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) today announces that regulatory filings for ORPATHYS ® (savolitinib) in ...
Exploratory research in mSystems finds broader small-bowel gene-expression changes in ISO than in methanogen overgrowth or ...
Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, ...
SonicForce is an investigational coronary intravascular lithotripsy (IVL) system that uses acoustic pressure waves, similar ...
The Foundation's CLIA-certified laboratory combines DNA methylation profiling, MGMT status, copy-number variation analysis ...
Analyses presented at TCT highlight how patient selection, timely Impella support and consistent care protocols may help ...
INOVIO delivers a new nonsurgical treatment option with a broad indication for adults living with RRP, a rare and ...
Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed ...
The live webcasts can be accessed on the company’s investor relations website at investors.gilead.com. The replays will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results